although
rna
interfer
rnai
becom
ubiquit
laboratori
tool
sinc
discoveri
year
ago
vivo
deliveri
select
cell
type
remain
major
technic
challeng
report
use
lentivir
vector
longterm
vivo
deliveri
rnai
select
resid
alveolar
macrophag
am
key
immun
effector
cell
lung
demonstr
therapeut
potenti
approach
rnaibas
downregul
rela
compon
proinflammatori
transcript
regul
nuclear
factor
b
nfb
key
particip
lung
diseas
pathogenesi
vivo
rnai
deliveri
result
decreas
induct
nfb
downstream
neutrophil
chemokin
transduc
am
well
attenu
lung
neutrophilia
follow
stimul
lipopolysaccharid
lp
concurr
deliveri
novel
lentivir
report
vector
lentinfblucgfp
track
vivo
express
nfb
target
gene
real
time
critic
step
toward
extend
rnaibas
therapi
longstand
lung
diseas
applic
system
reveal
resid
am
persist
airspac
mice
follow
resolut
lpsinduc
inflamm
thu
allow
local
cell
use
effect
vehicl
prolong
rnai
deliveri
diseas
set
although
manipul
vivo
gene
express
use
rnai
technolog
major
goal
medic
research
abil
cell
typespecif
fashion
avoid
offtarget
knockdown
remain
elus
lung
attract
target
organ
rnaibas
therapi
owe
air
interfac
uniqu
architectur
offer
entir
epitheli
surfac
potenti
target
inhal
deliveri
previou
work
har
rnai
treatment
acut
pulmonari
infect
shown
promis
target
gene
knockdown
transient
restrict
specif
lung
lineag
specif
rnai
express
strongli
associ
mechan
deliveri
draw
approach
pioneer
deliveri
tradit
gene
therapi
varieti
methodolog
use
deliv
small
interf
rna
sirna
cell
tissu
vari
degre
success
approach
includ
introduct
sirna
directli
target
tissu
addit
ligand
coat
stabil
molecul
help
provid
specif
deliveri
achiev
prolong
express
viral
vector
use
deliv
short
hairpin
rna
shrna
control
pol
ii
pol
iii
promot
lentivir
vector
particular
use
knock
gene
express
direct
inject
target
tissu
abil
induc
lineagespecif
express
complex
tissu
lung
howev
proven
challeng
improv
upon
exist
technolog
extend
rnaibas
therapi
chronic
lung
diseas
deliveri
system
need
target
specif
lung
cell
type
achiev
sustain
verifi
knockdown
recent
report
lentivirusbas
method
manipul
gene
express
specif
alveolar
macrophag
am
adapt
approach
deliv
shrna
key
immun
effector
cell
lung
establish
success
knockdown
report
gene
vivo
appli
method
downregul
express
gene
central
inflammatori
respons
lung
rela
subunit
transcript
factor
nuclear
factor
b
nfb
confirm
success
sustain
knockdown
target
cell
introduc
novel
lentivirusbas
approach
track
transcript
factor
activ
live
anim
demonstr
shrnatreat
anim
exhibit
diminish
activ
nfb
knockdown
downstream
chemokin
decreas
neutrophil
influx
respons
intratrach
instil
lipopolysaccharid
lp
unexpectedli
studi
reveal
lentivir
transduc
resid
am
persist
airspac
follow
resolut
nfb
inflammatori
activ
suggest
cell
conveni
vehicl
select
sustain
deliveri
rnai
lung
parenchyma
test
lentivir
deliveri
shrna
transduc
cell
line
contain
singl
copi
enhanc
green
fluoresc
protein
egfp
report
gene
lentivir
vector
lentidsredshgfp
modifi
form
publish
vector
plvthm
express
dsred
fluoresc
protein
togeth
shrna
sequenc
known
knock
express
gfp
figur
increas
multipl
infect
observ
dosedepend
decrement
gfp
mean
fluoresc
intens
protein
product
consist
knockdown
transgen
figur
b
c
gfp
knockdown
observ
cell
transduc
control
vector
express
scrambl
version
shgfp
sequenc
lentidsredscrambl
use
previous
publish
method
specif
transduct
am
vivo
next
use
intratrach
instil
lentidsredshgfp
lentidsredscrambl
vector
figur
virionsmous
test
construct
transgen
mice
ubiquit
express
gfp
report
gene
control
actin
promot
actingfp
mice
four
week
lentiviru
transduc
dsred
am
lavag
mice
treat
lentidsredshgfp
significantli
lower
level
gfp
express
quantifi
mean
fluoresc
intens
suggest
could
achiev
knockdown
vivo
gene
express
previou
work
demonstr
cell
transduc
lentiviru
method
resid
am
surfac
marker
profil
dim
although
epitheli
endotheli
cell
transduc
use
approach
base
tropism
vesicular
stomat
viru
g
viral
envelop
found
lentivir
transduct
subset
lung
dendrit
cell
occur
transcript
factor
nfb
implic
varieti
lung
diseas
includ
pneumonia
acut
lung
injuri
emphysema
malign
although
studi
suggest
nfb
signal
intrigu
target
knockdown
lung
nonselect
global
inhibit
nfb
highli
toxic
evidenc
embryon
lethal
knockout
mous
contrast
lineagespecif
knockout
intratrach
instil
lentiviru
allow
us
specif
transduc
resid
am
reason
select
knockdown
nfb
signal
lung
might
achiev
use
method
therefor
modifi
rnaiexpress
vector
knock
nfb
famili
member
known
activ
lung
clone
previous
publish
shrna
sequenc
known
target
scrambl
version
sequenc
plvthm
creat
vector
lentigfpscrambl
figur
test
efficaci
vitro
assess
effect
lp
stimul
raw
macrophag
follow
transduct
fifteen
passag
lentivir
transduct
raw
cell
express
result
persist
knockdown
mrna
reduc
nfbdepend
cytokin
secret
baselin
schemat
lentidsredshgfp
vector
design
deliveri
shrna
sequenc
target
enhanc
green
fluoresc
protein
egfp
addit
constitut
express
dsred
control
elong
factor
promot
bp
sens
sequenc
depict
red
target
egfp
follow
link
loop
sequenc
blue
complementari
antisens
sequenc
green
scrambl
version
sequenc
use
control
code
sequenc
flank
rna
pol
iii
transcript
start
cccc
stop
ttttt
sequenc
express
driven
promot
element
teto
preced
promot
allow
tetracyclin
induc
promot
presenc
addit
construct
express
repressor
fusion
protein
ttrkrab
absenc
ttrkrabexpress
construct
use
construct
constitut
drive
shrna
express
vector
manuscript
includ
woodchuck
hepat
viru
posttranscript
regulatori
element
wpre
augment
gene
express
level
presenc
lp
stimul
figur
supplementari
figur
western
blot
lysat
clonal
popul
raw
macrophag
similarli
found
less
protein
transduc
clone
transduc
lentigfpscrambl
figur
next
examin
whether
treatment
would
result
knockdown
nfb
activ
vivo
administ
recipi
mice
harvest
am
bronchoalveolar
lavag
bal
week
later
sort
isol
transduc
gfp
am
mrna
level
measur
quantit
realtim
pcr
mrna
significantli
reduc
transduc
gfp
am
lavag
treat
anim
comparison
scrambletr
control
figur
test
whether
mrna
knockdown
occur
transduc
am
spread
resid
lung
am
next
quantifi
mrna
level
compar
sort
transduc
am
gfp
nontransduc
gfp
am
group
mice
treat
control
versu
express
vector
subset
mice
group
also
expos
subsequ
lp
hour
macrophag
harvest
screen
alter
downstream
nfbdepend
signal
g
four
week
lentiviru
fewer
neutrophil
found
bal
cytospin
mice
treat
lentigfpscrambl
treat
control
follow
lp
n
per
group
p
p
p
psi
packag
signal
gfp
green
fluoresc
protein
gfp
versu
gfp
am
figur
f
found
knockdown
select
occur
gfp
am
persist
set
lpsinduc
inflamm
addit
decreas
induct
nfbdepend
chemokin
kc
chemotact
neutrophil
note
transduc
am
comparison
nontransduc
am
knockdown
significantli
affect
express
sever
gene
known
nfb
depend
interleukin
tumor
necrosi
factor
tnf
supplementari
figur
surprisingli
express
also
significantli
diminish
am
transduc
gfpscrambl
find
recapitul
later
timepoint
lentivir
treatment
suggest
transient
nonspecif
effect
lentivir
transduct
gene
express
resolv
time
supplementari
figur
effect
observ
nfbdepend
cytokin
express
downstream
result
nonspecif
knockdown
mrna
target
figur
evalu
suitabl
lentivirusbas
knockdown
longterm
vivo
applic
harvest
am
treat
mice
later
timepoint
week
follow
lentiviru
figur
two
repeat
experi
n
per
group
n
per
group
found
persist
knockdown
messag
restrict
transduc
gfp
am
week
lentivir
treatment
supplementari
figur
sampl
knockdown
gene
express
restrict
lentivir
transduc
am
evid
spillov
nontransduc
am
knockdown
transduc
subset
am
also
result
decreas
presenc
neutrophil
bal
lpsexpos
mice
suggest
function
relev
antiinflammatori
effect
persist
week
rnai
deliveri
n
per
group
p
figur
next
compar
knockdown
result
complet
ablat
use
mice
delet
follow
cremedi
excis
myeloid
cell
includ
am
lysmcr
x
mice
hereaft
assess
effect
rel
level
global
lung
inflammatori
signal
analyz
level
differ
cytokin
bal
fluid
balf
treat
mice
mice
follow
lp
exposur
epitheli
cell
well
am
experi
nfb
activ
mediat
via
lp
bind
tolllik
receptor
anticip
amspecif
downregul
ablat
might
suffici
affect
global
lung
express
inflammatori
gene
expect
found
decreas
nfb
depend
cytokin
level
balf
mice
defici
result
either
rnai
deliveri
cremedi
excis
data
shown
perform
preliminari
test
lentinfblucgfp
raw
macrophag
overnight
infect
raw
macrophag
split
stimul
either
e
colideriv
lp
ngml
known
upregul
nfb
pathway
specif
ligat
tolllik
receptor
standard
media
neg
control
well
unstimul
state
lentinfbluc
gfptransduc
raw
macrophag
level
luminesc
detect
background
consist
either
minim
basal
level
nfb
signal
macrophag
cultur
plastic
basal
leak
luciferas
report
figur
ing
nfbdriven
luciferas
product
occur
subset
cell
analyz
flow
cytometri
determin
transduct
effici
illustr
figur
gfp
mean
fluoresc
intens
lp
stimul
unstimul
cell
ident
indic
ubcdriven
gene
express
second
posit
affect
nfb
bind
activ
figur
determin
transduct
lentinfblucgfp
result
lpsrespons
luciferas
activ
proceed
vivo
test
administ
lentinfblucgfp
control
lentivirus
constitut
express
either
gfp
neg
control
luciferas
posit
control
recipi
mice
follow
week
later
lp
illustr
figur
neg
control
mice
mice
treat
lentinfblucgfp
measur
background
luciferas
activ
photon
flux
imag
lp
exposur
figur
contrast
mice
treat
lentinfblucgfp
follow
either
ng
ng
lp
exhibit
luciferas
activ
local
thorax
consist
dose
respons
observ
luciferas
activ
lpstreat
anim
diminish
time
rais
possibl
either
resolut
nfb
activ
resid
cell
death
follow
lp
stimul
am
previous
presum
short
half
life
may
diminish
inflammatori
activ
suggest
rapid
dropout
transduc
am
expos
lp
might
expect
recent
literatur
instead
report
resid
am
persist
alveolar
space
follow
lp
issu
remain
controversi
lentiviru
tag
resid
am
abl
address
question
use
independ
experiment
approach
perform
bal
harvest
am
treat
mice
week
lp
stimul
time
point
decrement
nfbluciferas
report
signal
even
treatment
signific
dose
lp
high
percentag
lavag
am
found
gfp
suggest
tag
resid
am
persist
alveolar
space
follow
inflammatori
injuri
figur
occur
us
am
persist
alveolar
space
lp
treatment
might
lack
capac
respond
lp
explor
question
subset
am
lavag
anim
cultur
overnight
incub
media
without
lp
recapitul
vivo
find
am
lentinfblucgfp
treat
mice
control
increas
luminesc
respons
lp
stimul
figur
result
demonstr
tag
am
persist
lp
stimul
fact
capabl
upregul
nfb
activ
respons
repeat
lp
exposur
long
term
verifi
downregul
gene
express
desir
rnai
adapt
treatment
chronic
diseas
therefor
sought
determin
whether
could
track
knockdown
time
live
mice
determin
whether
lentinfb
report
vector
could
detect
shrnamedi
downregul
sort
singl
gfp
raw
cell
follow
transduct
scrambl
figur
expans
cultur
clone
subsequ
transduc
lentinfblucgfp
incub
lpscontain
control
media
observ
abrog
nfbdriven
luciferas
express
cell
figur
suggest
report
vector
could
use
visual
knockdown
adapt
approach
use
live
anim
devis
experi
use
mixtur
scrambl
alter
form
lentinfblucgfp
vector
describ
red
dtomato
fluorochrom
clone
second
posit
lentinfblucdtomato
figur
prepar
experi
perform
inject
mixtur
lentivirus
contain
either
red
green
fluorochrom
demonstr
signific
percentag
am
transduc
construct
mixtur
two
lentivirus
administ
via
instil
supplementari
figur
two
week
administ
lentinfblucdtomato
mixtur
group
mice
perform
photon
flux
imag
hour
administr
lp
consist
previou
result
scrambletr
group
similar
lowlevel
luciferas
activ
local
thorax
instil
lp
figur
group
found
significantli
increas
luciferas
activ
follow
lp
expect
howev
increas
luciferas
activ
follow
lp
significantli
attenu
group
consist
diminish
nfb
activ
set
knockdown
confirm
diminish
nfb
driven
luciferas
level
result
knockdown
rather
dropout
transduc
cell
perform
bal
treat
mice
hour
lp
stimul
fluoresc
microscopi
flow
cytometri
reveal
differ
percentag
am
transduc
lentinfbdtomato
two
experiment
group
indic
cell
death
respons
differ
nfbdriven
luciferas
activ
figur
supplementari
figur
presenc
dtomato
experi
result
lower
usual
transduct
percentag
follow
lp
exposur
possibl
result
toxic
effect
fluorochrom
report
repeat
experi
substitut
lentinfblucgfp
result
higher
transduct
effici
consist
typic
result
data
shown
articl
describ
durabl
knockdown
nfb
signal
am
key
innat
immun
cell
popul
lung
techniqu
result
sustain
downregul
longliv
lung
resid
celltyp
suggest
potenti
alter
cours
chronic
inflammatori
condit
lung
knockdown
turn
diminish
lpsinduc
influx
neutrophil
lung
demonstr
function
signific
previous
report
induct
inflammatori
cytokin
neutrophil
recruit
dampen
absenc
myeloid
pneumococc
pneumonia
data
present
consist
previou
find
suggest
role
nfb
signal
inflammatori
respons
lung
extend
beyond
pneumonia
includ
type
lung
injuri
well
rel
influenc
specif
lung
cell
type
respons
inflammatori
injuri
topic
yet
well
address
scientif
literatur
intrigu
question
rais
research
whether
knockdown
subset
am
suffici
decreas
nfb
signal
entir
lung
am
present
alveolar
space
secret
cytokin
effector
molecul
directli
epitheli
line
fluid
potenti
influenc
gene
express
alveolar
epitheli
cell
previous
publish
data
indic
critic
whole
lung
cytokin
product
earli
pneumococc
pneumonia
literatur
whole
suggest
resid
am
alveolar
epitheli
cell
nfb
signal
ultim
contribut
inflammatori
respons
lung
data
support
hypothesi
neither
knockdown
complet
delet
result
decreas
epitheli
line
fluid
cytokin
level
experi
addit
studi
use
crelox
system
induc
epitheli
lineagespecif
ablat
signal
might
help
address
issu
futur
effect
lentigfpscrambl
express
transduc
am
earli
timepoint
rais
question
nonspecif
effect
lentivir
infect
inflammatori
respons
longtermin
repeat
ltr
promot
known
contain
nfb
bind
site
could
conceiv
affect
nfb
signal
transduc
cell
howev
bulk
hiv
genom
includ
transcript
factor
bind
site
delet
phage
plvthm
vector
use
experi
safeti
purpos
minim
ltrassoci
transcript
interfer
altern
potenti
explan
find
might
induct
immunolog
toler
caus
lentivir
infect
antigen
present
cell
am
dendrit
cell
featur
experi
lentivir
infect
known
activ
tolllik
receptor
signal
transduc
dendrit
cell
vitro
vivo
although
anoth
report
find
subsequ
toler
lp
stimul
lentitransduc
bone
marrow
deriv
dendrit
cell
cultur
import
differ
studi
exist
includ
vivo
approach
time
durat
lp
stimul
confirm
find
could
broad
implic
clinic
applic
lentivir
gene
therapi
addit
tool
manipul
track
gene
express
describ
report
resid
am
persist
alveolar
space
even
signific
inflammatori
lp
injuri
extend
recent
publish
observ
prolong
life
span
am
quiescent
inflam
lung
find
togeth
previou
similar
observ
set
elastaseand
acut
cigarett
smokeinduc
lung
inflamm
demonstr
resid
am
addit
possess
long
life
span
character
capac
withstand
broad
varieti
inflammatori
insult
togeth
access
gene
transfer
featur
suggest
good
potenti
target
gene
therapi
design
alter
cours
inflammatori
lung
diseas
potenti
toxic
associ
constitut
shrna
express
concern
partial
address
studi
warrant
investig
although
result
clearli
demonstr
decreas
surviv
am
issu
particularli
signific
target
molecul
nfb
mani
downstream
target
known
affect
cell
surviv
set
injuri
inde
constitut
highlevel
express
shrna
molecul
could
render
basic
cellular
gene
silenc
apparatu
unavail
microrna
involv
natur
cellular
metabol
anticip
use
induc
promot
system
allow
tempor
control
gene
express
help
address
issu
manuscript
describ
novel
lentivir
vector
allow
us
measur
activ
transcript
factor
nfb
live
anim
real
time
contrast
convent
method
measur
transcript
factor
activ
vector
allow
linear
track
activ
individu
live
anim
characterist
mani
potenti
advantag
least
need
fewer
anim
perform
measur
multipl
time
point
comparison
exist
method
expect
valuabl
tool
investig
perform
studi
transcript
factor
vivo
studi
demonstr
techniqu
specif
deliveri
shrna
resid
am
key
immun
effector
cell
lung
tool
provid
new
approach
studi
function
could
potenti
use
alter
cours
lung
diseas
am
implic
chronic
obstruct
pulmonari
diseas
pulmonari
alveolar
proteinosi
tuberculosi
other
although
tropism
vesicular
stomat
viru
g
pseudotyp
lentiviru
am
rather
lung
epithelium
system
result
architectur
polar
epitheli
cell
surfac
recent
publish
literatur
suggest
lentivirus
engin
achiev
transduct
cell
type
display
specif
cell
receptor
thu
potenti
allow
extens
approach
cell
type
method
anim
studi
luciferas
imag
transgen
chicken
actingfp
mice
jackson
laboratori
bar
harbor
mice
defici
myeloid
gener
cross
lysmcr
mice
mice
produc
lysmcr
tg
loxploxp
lysmcr
loxploxp
ff
litterm
maintain
pathogenfre
facil
anim
studi
approv
institut
anim
care
use
committe
boston
univers
school
medicin
vector
viral
product
replic
incompet
lentivirus
use
gene
transfer
experi
creat
use
plasmid
transfect
procedur
previous
describ
briefli
cell
transfect
phage
plvthm
backbon
lentivir
vector
togeth
four
express
vector
encod
packag
protein
gagpol
rev
tat
g
protein
vesicular
stomat
viru
viral
supernat
concentr
approxim
ultracentrifug
titer
vector
perform
infect
cell
previous
publish
viral
titer
approxim
ml
typic
achiev
use
protocol
plvthm
previous
publish
lentivir
backbon
express
gfp
report
gene
control
ubiquit
promot
contain
clone
site
insert
shrna
molecul
ltr
pol
iii
promot
element
teto
preced
promot
allow
tetracyclin
tet
induc
promot
presenc
addit
construct
express
repressor
fusion
protein
ttrkrab
absenc
ttrkrabexpress
construct
use
experi
describ
herein
construct
constitut
drive
shrna
express
adapt
plvthm
use
gfp
knockdown
experi
cdna
encod
variant
red
fluoresc
protein
adapt
discosoma
sp
dsredexpress
clontech
mountain
view
ca
amplifi
pcr
pmei
spei
restrict
site
ad
end
respect
amplicon
clone
plvthm
backbon
downstream
promot
ligat
pmeispei
cohes
end
previous
publish
shrna
target
egfp
adapt
clone
plvthm
addit
mlui
clai
restrict
site
insert
ltr
use
standard
direct
clone
techniqu
scrambl
version
shrna
sequenc
gener
use
onlin
tool
design
purpos
sirnawizard
invitrogen
carlsbad
ca
vector
creat
use
sequenc
use
neg
control
vector
specifi
experi
phage
lentivir
backbon
optim
selfinactiv
lentivir
ltr
nonrepl
vector
deriv
origin
phrcmvlacz
vector
previous
describ
naldini
et
al
cdna
encod
nfb
enhanc
sequenc
upstream
minim
ta
promot
herp
simplex
viru
follow
firefli
luciferas
gene
amplifi
pcr
plasmid
nf
bluciferas
clontech
spei
bamhi
restrict
site
attach
end
amplicon
clone
first
posit
phage
backbon
ligat
speibamhi
cohes
end
monitor
gfp
report
gene
knockdown
cell
line
contain
singl
integr
copi
gfpexpress
vector
gener
follow
cell
transduc
limit
dilut
multipl
infect
lentivir
vector
encod
gfp
singl
cell
sort
individu
well
well
plate
singl
clone
pick
passag
knockdown
studi
detail
text
quantif
vitro
gene
express
protein
level
gfp
cell
lysat
raw
cell
lysat
quantifi
western
blot
use
rabbit
polyclon
antigfp
primari
antibodi
abcam
rabbit
antihuman
primari
antibodi
cell
signal
technolog
danver
respect
analysi
express
level
total
rna
prepar
rneasi
mini
kit
qiagen
valencia
ca
accord
manufactur
protocol
follow
northern
analysi
use
plabel
cdna
probe
dehydrogenas
previous
describ
probe
gener
pcr
amplif
mous
cdna
use
primer
evalu
nfb
depend
cytokin
level
cell
cultur
supernat
perform
mous
cytokin
protein
antibodybas
assay
raybiotech
norcross
ga
per
manufactur
instruct
luciferas
express
level
raw
cell
quantifi
use
dualglo
luciferas
assay
system
promega
glomax
multidetector
plate
reader
promega
fitchburg
wi
prepar
lentiviru
lp
inject
mice
anesthet
isofluran
concentr
lentivir
supernat
mcl
lp
either
ng
ng
mcl
phosphatebuff
salin
list
biolog
laboratori
deliv
via
bluntend
needl
posterior
oropharynx
tracheal
entranc
previous
describ
aspir
fluid
bolu
upon
subsequ
inhal
confirm
recipi
investig
visual
viral
supernat
mix
lipofectamin
final
volvol
invitrogen
instil
increas
transduct
effici
quantif
vivo
gene
express
two
week
scrambl
rna
isol
sort
gfp
am
use
rneasi
micro
kit
qiagen
rna
revers
transcrib
use
taqman
revers
transcript
reagent
appli
biosystem
carlsbad
ca
quantit
pcr
cdna
perform
use
steponer
time
pcr
system
taqman
primer
appli
biosystem
reaction
perform
duplic
use
dilut
cdna
mrna
express
level
normal
rrna
quantif
rel
gene
express
present
fold
chang
compar
relev
baselin
calcul
use
ct
method
noninvas
bioluminesc
imag
imag
mice
anesthet
isofluoran
mcl
dluciferin
substrat
mgml
xenogen
alam
ca
administ
intraperiton
inject
seri
bioluminesc
imag
taken
minut
luciferin
inject
use
xenogen
ivi
imag
calip
life
scienc
hopkinton
photon
output
quantifi
plateau
time
cours
use
live
imag
softwar
xenogen
express
photon
flux
ps
euthanasia
bal
perform
cannul
trachea
instil
aspir
three
consecut
mcl
aliquot
phosphatebuff
salin
per
mous
bal
cell
fluid
separ
centrifug
first
fraction
balf
store
subsequ
analysi
cytokin
level
cell
fraction
pool
analysi
flow
cytometri
cytospin
rna
extract
cytospin
cell
count
perform
blind
fashion
minimum
cell
count
per
sampl
neutrophil
quantifi
percent
nucleat
cell
bal
flow
cytometri
perform
unstain
bal
cell
quantifi
transduct
effici
percentag
bal
cell
gfp
dsred
case
propidium
iodid
mcgml
molecular
probe
eugen
ad
cell
sampl
exclud
dead
cell
analysi
gate
algorithm
use
identifi
am
within
bal
cell
popul
previous
publish
flow
cytometri
perform
bd
facscan
bd
lsr
ii
bd
bioscienc
instrument
cell
sort
experi
perform
moflo
flow
cytomet
dakocytom
fort
collin
co
analysi
raw
data
complet
use
flowjo
softwar
treestar
balf
cytokin
profil
analysi
balf
aliquot
mice
expos
lentivirus
lp
analyz
level
cytokin
multiplex
cytokin
array
millipor
billerica
analysi
perform
use
qiagen
liquichip
machin
analyz
use
liquichip
analyz
softwar
qiagen
cytokin
assay
kc
tnf
gcsf
lix
statist
twotail
student
ttest
use
compar
specifi
group
except
data
display
supplementari
figur
nonparametr
mannwhitney
test
appli
studi
differ
group
consid
statist
signific
p
experi
describ
figur
one
mous
group
exclud
postlp
analysi
failur
aspir
intratrach
administ
lp
error
bar
figur
repres
standard
error
mean
sem
figur
nfb
depend
cytokin
product
suppress
transduc
raw
macrophag
stimul
lp
figur
gene
express
gfp
gfp
bal
cell
week
gfpscrambl
lenti
hour
lp
ng
figur
fluoresc
activ
cell
sorter
analysi
lavag
am
mous
treat
mixtur
red
cmvdsred
green
nfblucgfp
lentiviru
figur
fluoresc
activ
cell
sorter
analysi
lavag
am
mice
treat
mixtur
lentinfblucdtomato
scrambl
intratrach
lp
demonstr
similar
percentag
doubl
posit
am
group
